Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Peripheral T-cell lymphoma unspecified refractory
ADR ID BADD_A10661
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.06      Peripheral T-cell lymphomas NEC
01.11.06.002      Peripheral T-cell lymphoma unspecified refractory
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.06      Peripheral T-cell lymphomas NEC
16.17.06.002      Peripheral T-cell lymphoma unspecified refractory
Description Not Available
MedDRA Code 10034626
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Diffuse large cell lymphoma (Peripheral T-cell lymphoma unspecified) refractory | Diffuse mixed small and large cell lymphoma (Peripheral T-cell lymphoma unspecified) refractory | Diffuse small cleaved cell lymphoma (Peripheral T-cell lymphoma unspecified) refractory | Large cell immunoblastic lymphoma (Peripheral T-cell lymphoma unspecified) refractory | Lymphoepithelioid lymphoma (Kiel Classification) refractory | Peripheral T-cell lymphoma unspecified refractory | Pleomorphic medium and large T-cell lymphoma (Kiel Classification) refractory | Pleomorphic small T-cell lymphoma (Kiel Classification) refractory | Subcutaneous panniculitic T-cell lymphoma (Provisional subtype) refractory | T-immunoblastic lymphoma (Peripheral T-cell lymphoma unspecified) (Kiel Classification) refractory | T-immunoblastic lymphoma (Peripheral T-cell lymphoma unspecified) refractory | T-zone lymphoma (Kiel Classification) refractory
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000241%
The 1th Page    1    Total 1 Pages